Prof. Flavia Indrio reflects on the main take-home messages from the congress, which brought together 32 leading international experts in microbiota research, allergy, nutrition, gut-brain axis and lung disease.
Paul Wilmes, University of Luxembourg, explores the concept of infective competence within a One Health framework.
E. coli 541-15 helps the colon recruit key immune cells that can develop into macrophages.
Computer models combining oral bacteria, their metabolic functions, and saliva chemicals could better distinguish obese from healthy individuals compared with clinical measurements alone.
The team developed a machine-learning model using 34 metabolites that could reliably identify depressed individuals.
Piergiorgio Natali (Mediterranean Task force for Cancer Control) discusses the importance of improving functional foods as a strategy to support health, particularly during aging.
A youthful gut microbiota can improve the regenerative function of aged intestinal stem cells.
VOS, an FDA-approved oral microbiota therapy, has been shown to reduce infection risk compared to traditional fecal transplants.
Gut microbes can influence cancer outcomes by regulating nutrient availability and uptake in immune cells.
Lorenza Putignani, Pediatric Hospital Bambino Gesù, Italy, discusses translational research in the microbiome field.
